Prosecution Insights
Last updated: May 29, 2026

Examiner: GOLDBERG, JEANINE ANNE

Tech Center 3700 • Art Units: 1634 1682 3791

This examiner grants 46% of resolved cases

Performance Statistics

46.0%
Allow Rate
-24.0% vs TC avg
885
Total Applications
+40.4%
Interview Lift
1269
Avg Prosecution Days
Based on 817 resolved cases, 2023–2026

Rejection Statute Breakdown

3.4%
§101 Eligibility
19.1%
§102 Novelty
35.1%
§103 Obviousness
19.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18020587 COMPOSITIONS, PANELS, AND METHODS FOR CHARACTERIZING CHRONIC LYMPHOCYTIC LEUKEMIA Non-Final OA President and Fellows of Harvard College
18110341 METHODS AND KITS FOR PREDICTING CANCER PROGNOSIS AND METASTASIS Non-Final OA The Regents of the University of California
17776159 Method For Determining the Presence of Intestinal Parasites Non-Final OA Gen-Probe Incorporated
17932132 METHODS AND REAGENT FOR DIAGNOSING BIPOLAR DISORDER Non-Final OA Massachusetts Institute of Technology
17402018 GENETIC ABNORMALITIES IN PLASMA CELL DYSCRASIAS Non-Final OA Dana-Farber Cancer Institute, Inc.
17819908 USE OF GENOMIC SIGNATURES TO PREDICT RESPONSIVENESS OF PATIENTS WITH PROSTATE CANCER TO POST-OPERATIVE RADIATION THERAPY Non-Final OA THE REGENTS OF THE UNIVERSITY OF MICHIGAN
18215054 SYSTEM AND METHOD FOR AUTOMATED SINGLE CELL PROCESSING AND ANALYSES Final Rejection Bio-Rad Laboratories, Inc.
18251528 MULTIPLEX DETECTION OF BACTERIAL RESPIRATORY PATHOGENS Non-Final OA Becton, Dickinson and Company
18285876 ISOTHERMAL AMPLIFICATION-BASED DETECTION OF SHRIMP PATHOGENS Non-Final OA ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
17320739 NOVEL MRNA BASED PROGNOSTIC INDEX DERIVED FROM DIFFERENTIAL EXPRESSION ANALYSIS IMPROVES OVERALL SURVIVAL ESTIMATES IN GLIOBLASTOMA Final Rejection ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
18004788 SEX DETERMINATION MARKERS IN MULLETS AND METHODS OF USING THEREOF Non-Final OA THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION
17631597 BIOMARKER FOR DIAGNOSING PANCREATIC CANCER, AND USE THEREOF Non-Final OA SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
17399920 CLASSIFICATION OF SUBTYPES OF KIDNEY TUMORS USING DNA METHYLATION Non-Final OA UNIVERSITY OF SOUTHERN CALIFORNIA
17727128 DETECTING ESOPHAGEAL DISORDERS Final Rejection Exact Sciences Corporation
18416592 METHOD FOR PREPARING NUCLEIC ACID SAMPLE Final Rejection KAO Corporation
18015311 METHOD FOR DETECTING SEVERITY OF ATOPIC DERMATITIS Final Rejection KAO CORPORATION
17922565 METHOD FOR DETECTING ATOPIC DERMATITIS Final Rejection KAO CORPORATION
17759402 Method for Retaining Splicing RNAs in the Nucleus Based on Chemically Modified Antisense Oligonucleotides Final Rejection The Regents of the University of Colorado, a body corporate
18273389 A Method for Diagnosing Endometrial or Ovarian Carcinoma Non-Final OA Sorbonne Universite
17627254 AMPLIFICATION ASSAY FOR THE DETECTION OF ANAPLASMA PHAGOCYTOPHILUM Final Rejection THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY
18481035 COMPOSITION AND METHOD FOR DIAGNOSING BREAST CANCER USING EXTRACELLULAR VESICLE-MIRNA Non-Final OA University-Industry Foundation(UIF), Yonsei University
18007200 LONG NON-CODING RNA AS THERAPEUTIC TARGET IN CARDIAC DISORDERS AND CARDIAC REGENERATION Non-Final OA Medizinische Hochschule Hannover
17607731 KITS FOR DETECTING ONE OR MORE TARGET NUCLEIC ACID ANALYTES IN A SAMPLE AND METHODS OF MAKING AND USING THE SAME Final Rejection Meso Scale Technologies, LLC.
18287849 GENE POLYMORPHISM MARKERS FOR DETERMINING SKIN TURNOVER AND HYPER-KERATINIZATION AND USE THEREOF Non-Final OA LG HOUSEHOLD & HEALTH CARE LTD.
18427083 PROSTATE CANCER GENE PROFILES AND METHODS OF USING THE SAME Final Rejection THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.
18282159 REAGENT FOR DETECTING EXPRESSION LEVEL OF HUMAN HISTAMINE RECEPTOR HRH4 MRNA, KIT AND DETECTION METHOD Final Rejection HANGZHOU ZHEDA DIXUN BIOLOGICAL GENE ENGINEERING CO., LTD
18251147 A METHOD FOR SINGLE-CELL NASCENT RNA LABELING AND SEQUENCING Final Rejection SINGLERON (NANJING) BIOTECHNOLOGIES, LTD.
18212371 SELECTIVE ENRICHMENT Non-Final OA Harbinger Health, Inc.
18034571 STRATIFICATION METHODS FOR ASSESSING THE PROGRESSION AND RISK OF ADVANCED COLORECTAL ADENOMA AND COLORECTAL CANCER Non-Final OA SOCIETE DE COMMERCIALISATION DES PRODUITS DE LA RECHERCHE APPLIQUEE SOCPRA SANTE ET HUMAINES, S.E.C.
18076447 PIS GENOTYPE DETECTION METHOD FOR GOATS Final Rejection QINGDAO AGRICULTURAL UNIVERSITY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month